Aseptic Processing Consult ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2020
N/A
2021
N/A
2022
N/A
2023
2023/12
2024
2024/12
Bankruptcy risk for industry  1.0% 1.0% 1.0% 1.0% 1.0%  
Bankruptcy risk  0.0% 0.0% 0.0% 4.7% 4.8%  
Credit score (0-100)  0 0 0 44 45  
Credit rating  N/A N/A N/A BBB BBB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2020
N/A
2021
N/A
2022
N/A
2023
2023/12
2024
2024/12

Net sales  0 0 0 0 0  
Gross profit  0.0 0.0 0.0 12,841 15,967  
EBITDA  0.0 0.0 0.0 4,380 4,442  
EBIT  0.0 0.0 0.0 4,380 4,440  
Pre-tax profit (PTP)  0.0 0.0 0.0 4,380.5 4,393.8  
Net earnings  0.0 0.0 0.0 3,398.1 3,401.7  
Pre-tax profit without non-rec. items  0.0 0.0 0.0 4,380 4,394  

 
See the entire income statement

Balance sheet (kDKK) 
2020
N/A
2021
N/A
2022
N/A
2023
2023/12
2024
2024/12

Tangible assets total  0.0 0.0 0.0 0.0 107  
Shareholders equity total  0.0 0.0 0.0 3,438 3,442  
Interest-bearing liabilities  0.0 0.0 0.0 0.0 117  
Balance sheet total (assets)  0.0 0.0 0.0 6,516 5,295  

Net Debt  0.0 0.0 0.0 -2,470 -2,097  
 
See the entire balance sheet

Volume 
2020
N/A
2021
N/A
2022
N/A
2023
2023/12
2024
2024/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 0.0 0.0 12,841 15,967  
Gross profit growth  0.0% 0.0% 0.0% 0.0% 24.3%  
Employees  0 0 0 9 11  
Employee growth %  0.0% 0.0% 0.0% 0.0% 22.2%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 0 0 6,516 5,295  
Balance sheet change%  0.0% 0.0% 0.0% 0.0% -18.7%  
Added value  0.0 0.0 0.0 4,380.3 4,442.2  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 105  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 0.0 0.0 1.0 2.0  

Profitability 
2020
N/A
2021
N/A
2022
N/A
2023
2023/12
2024
2024/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 0.0% 0.0% 34.1% 27.8%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% 0.0% 0.0% 67.2% 75.2%  
ROI %  0.0% 0.0% 0.0% 127.4% 126.9%  
ROE %  0.0% 0.0% 0.0% 98.8% 98.9%  

Solidity 
2020
N/A
2021
N/A
2022
N/A
2023
2023/12
2024
2024/12
Equity ratio %  0.0% 0.0% 0.0% 52.8% 65.0%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% 0.0% 0.0% -56.4% -47.2%  
Gearing %  0.0% 0.0% 0.0% 0.0% 3.4%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 0.0% 84.0%  

Liquidity 
2020
N/A
2021
N/A
2022
N/A
2023
2023/12
2024
2024/12
Quick Ratio  0.0 0.0 0.0 2.1 2.7  
Current Ratio  0.0 0.0 0.0 2.1 2.7  
Cash and cash equivalent  0.0 0.0 0.0 2,470.1 2,214.3  

Capital use efficiency 
2020
N/A
2021
N/A
2022
N/A
2023
2023/12
2024
2024/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 0.0 0.0 3,363.4 3,217.5  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2020
N/A
2021
N/A
2022
N/A
2023
2023/12
2024
2024/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 487 404  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 487 404  
EBIT / employee  0 0 0 487 404  
Net earnings / employee  0 0 0 378 309